Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TRIP

Financiado

Cerrado

Translational Research into Psychiatric disorders genetics genomics and neurob...

Translational Research into Psychiatric disorders genetics genomics and neurobiology of psychosis and autism Psychiatric disorders such as schizophrenia, bipolar disorder and autism, constitute an extraordinarily high public health burden. Few novel treatments have emerged in recent years, because their aetiology is poorly understood. Th... ver más

31/05/2016

KINGS COLLEGE LOND...

714K€

Presupuesto del proyecto: 714K€

Líder del proyecto

KINGS COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-05-31 No tenemos la información de la convocatoria

0% 80% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

KINGS COLLEGE LONDON

0.00€ | Lider

UMC UTRECHT

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

GENCODYS Genetic and Epigenetic Networks in Cognitive Dysfunction 16M€ Cerrado

PSYCHCNVS Copy number variations conferring risk of psychiatric disord... 4M€ Cerrado

SAF2015-68341-R GENETICA Y EPIGENETICA DE TRASTORNOS PSIQUIATRICOS: TRASTORN... 218K€ Cerrado

GACPD Next Generation Sequencing to Identify Genes Underlying Extr... 100K€ Cerrado

GENOVAR Sequence based strategies to identify genetic variation asso... 1M€ Cerrado

SAF2012-33484 ANALISIS CRUZADO DE TRASTORNOS PSIQUIATRICOS: CONTRIBUCION D... 140K€ Cerrado

Líder del proyecto

KINGS COLLEGE LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 714K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Psychiatric disorders such as schizophrenia, bipolar disorder and autism, constitute an extraordinarily high public health burden. Few novel treatments have emerged in recent years, because their aetiology is poorly understood. The recent development of new, high resolution, high-throughput research technologies, including large-scale genetic studies using microarrays and genome sequencing, high-resolution neuroimaging, neurobiology and medical/bioinformatics provide an opportunity to advance the field rapidly through the translation of knowledge on fundamental aetiology into benefit for the patient. TRiP is a joint initiative by five of the world’s leading psychiatric research centres, two in Europe and one in the USA with two emerging powerhouses of neuroscience research in China, formed to accelerate basic and clinical research into mental illness. These key research players will exchange state of the art research methodology and provide training in psychiatry research. The international dimension in TRiP directly addresses the IRSES action, which encourages long-term research collaboration between MS/AC and eligible third country partners. The participants are ideal partners, because of their world-class research expertise, complementarities, and track record of cooperation, which will result in enduring scientific exchange and collaboration between key players in the field in the EU, China and the USA. TRIP will harmonize state of the art research across the centres in order to tackle the most difficult research problems in biological psychiatry, allowing the harmonisation of phenotype measurements in patient populations, the development and dissemination of complex and advanced techniques and methodologies, the pooling of resources for direct comparison and combination of large datasets, the cross-disciplinary training of future leaders in this field and the translation of these findings for patient benefit, such as drug development and clinical genetics.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores